GCG and Alzheimer disease: In studies on AD mouse models, GLP-1 analogues reduced neuronal tau hyperphosphorylation, prevented synaptic loss, improved motor function, enhanced synaptic plasticity, attenuated memory and learning deficits and diminished beta amyloid plaque load in the brain [94,95].